Form 8-K - Current report:
SEC Accession No. 0001437749-25-007998
Filing Date
2025-03-17
Accepted
2025-03-17 16:07:47
Documents
14
Period of Report
2025-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20250304_8k.htm   iXBRL 8-K 33263
  Complete submission text file 0001437749-25-007998.txt   177739

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA noticker-20250314.xsd EX-101.SCH 3611
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20250314_def.xml EX-101.DEF 11816
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20250314_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20250314_pre.xml EX-101.PRE 12031
16 EXTRACTED XBRL INSTANCE DOCUMENT cont20250304_8k_htm.xml XML 2976
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 25744456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)